Inventor
MI SHA
US36 patents
⚠️ This page may combine multiple inventors who share the name “MI SHA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN MA INC
12 patentsUS9550798B2Jan 24, 2017
Compounds that are S1P modulating agents and/or ATX modulating agents
BIOGEN MA INC8 citations83
US10034869B2Jul 31, 2018
S1P modulating agents
BIOGEN MA INC2 citations73
US9808449B2Nov 7, 2017
S1P modulating agents
BIOGEN MA INC2 citations73
US9555050B2Jan 31, 2017
ATX modulating agents
BIOGEN MA INC4 citations72
US9522889B2Dec 20, 2016
ATX modulating agents
BIOGEN MA INC5 citations72
US9745375B2Aug 29, 2017
Compositions comprising antibodies to LINGO or fragments thereof
BIOGEN MA INC1 citations63
US10894040B2Jan 19, 2021
S1P modulating agents
BIOGEN MA INC0 citations62
US10406144B2Sep 10, 2019
SIP modulating agents
BIOGEN MA INC0 citations52
US10017506B2Jul 10, 2018
ATX modulating agents
BIOGEN MA INC0 citations52
US9944666B2Apr 17, 2018
Compounds that are S1P modulating agents and/or ATX modulating agents
BIOGEN MA INC0 citations52
US9796780B2Oct 24, 2017
LINGO-2 antagonists for treatment of conditions involving motor neurons
BIOGEN MA INC1 citations52
US10435467B2Oct 8, 2019
LINGO-1 antagonists and uses for treatment of demyelinating disorders
BIOGEN MA INC0 citations35
MI SHA
10 patentsUS8425910B2Apr 23, 2013
Composition comprising antibodies to LINGO or fragments thereof
MI SHA44 citations97
US8058406B2Nov 15, 2011
Composition comprising antibodies to LINGO or fragments thereof
MI SHA48 citations97
US8551476B2Oct 8, 2013
SP35 antibodies and uses thereof
MI SHA34 citations92
US8153580B2Apr 10, 2012
Nogo receptor binding protein
MI SHA17 citations92
US8128926B2Mar 6, 2012
Sp35 antibodies and uses thereof
MI SHA29 citations91
US8642040B2Feb 4, 2014
Methods for promoting myelination, neuronal survival and oligodendrocyte differentiation via administration of Sp35 or TrkA antagonists
MI SHA24 citations86
US8765662B2Jul 1, 2014
NOGO receptor binding protein
MI SHA6 citations84
US8486893B2Jul 16, 2013
Treatment of conditions involving demyelination
MI SHA8 citations84
US8609407B2Dec 17, 2013
Sp35 antibodies and uses thereof
MI SHA6 citations82
US8501178B2Aug 6, 2013
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
MI SHA7 citations82
BIOGEN IDEC INC
6 patentsUS9066984B2Jun 30, 2015
Sp35 antibodies and uses thereof
BIOGEN IDEC INC26 citations92
US7785829B2Aug 31, 2010
Nogo receptor binding protein
BIOGEN IDEC INC15 citations92
US7846438B2Dec 7, 2010
Methods of promoting neurite outgrowth with soluble TAJ polypeptides
BIOGEN IDEC INC8 citations84
US8894999B2Nov 25, 2014
Use of DR6 and p75 antagonists to promote survival of cells of the nervous system
BIOGEN IDEC INC10 citations83
US8932821B2Jan 13, 2015
NOGO receptor binding protein
BIOGEN IDEC INC3 citations62
US9068992B2Jun 30, 2015
Screening methods for identifying Sp35 antagonists
BIOGEN IDEC INC1 citations52
GENETICS INST
3 patentsUS6043344AMar 28, 2000
Human CTLA-8 and uses of CTLA-8-related proteins
GENETICS INST129 citations96
US6074849AJun 13, 2000
Polynucleotides encoding human CTLA-8 related proteins
GENETICS INST34 citations90
US6312921B1Nov 6, 2001
Secreted proteins and polynucleotides encoding them
GENETICS INST10 citations73